Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: Evidence from a US national survey

Digestive Diseases and Sciences

Volumn 57, Issue 12, 2012, Pages 3080-3091

  Gunnarsson, Candace ^a   Chen, Jie ^b,g   Rizzo, John A ^c   Ladapo, Joseph A ^d,e,h   Lofland, Jennifer H ^f  

^a S2 Statistical Solutions Inc   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f Janssen Scientific Affairs LLC   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h NEW YORK UNIVERSITY   (United States)

Author keywords

Costs and cost analysis; Crohn's disease; Health care costs; Health expenditures; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CROHN DISEASE; DEPRESSION; ECZEMA; ENTERITIS; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEPHROLITHIASIS; NEUROSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLEROSIS; STOMACH ULCER; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84871640598     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2289-y     Document Type: Article

References (40)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
2. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
3. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991;100:143-149.
4. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690-697.
5. Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984;29:913-920.
6. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104-110.
7. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology. 1989;97:900-904.
8. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
9. Lichtenstein GR, Hanauer SB, Sandborn WJ, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104:465-483.
10. Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2005;48:1997-2009.
11. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
12. Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña S. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007;19:73-78.
13. Joo M, Abreu-e-Lima P, Farraye F, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009;33:854-862.
14. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430-434.
15. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97-101.
16. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950-954.
17. Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol. 2000;95:677-683.
18. Hillson E, Dybicz S, Waters HC, et al. Health care expenditures in ulcerative colitis: the perspective of a self-insured employer. J Occup Environ Med. 2008;50:969-977.
19. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907-1913.
20. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med. 2008;50:1261-1272.
21. Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am J Gastroenterol. 2000;95:524-530.
22. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. Survey Background. Agency for Healthcare Research and Quality Web site. Available at: http://www.meps.ahrq.gov/mepsweb/about-meps/survey-back.jsp. Accessed March 12, 2009.
23. Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996-1997;33:373-389.
24. Cohen SB, DiGaetano R, Goksel H. Methodology Report #5: Estimation Procedures in the 1996 MEPS Household Component. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq.gov/mepsweb/data-files/ publications/mr5/mr5.shtml. Published May 1999. Accessed March 12, 2010.
25. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. MEPS-HC Response Rates by Panel. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq.gov/mepsweb/survey-comp/hc- response-rate.jsp. Accessed February 10, 2010.
26. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. MEPS Expenditures. MEPS-HC Summary Data Tables Technical Notes. Agency for Healthcare Research and Quality Web site. Available at: http://meps.ahrq. gov/mepsweb/survey-comp/hc-technical-notes.shtml#expenditures. Published May 2004. Accessed April 18, 2012.
27. Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. Value Health. 2001;4:329-334.
28. Cragg JG. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica. 1971;39:829-844.
29. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23:525-542.
30. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247-281.
31. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60:3546-3553.
32. United States Census Bureau. Table HI01. Health Insurance Coverage Status and Type of Coverage by Selected Characteristics: 2010 All Races. United States Census Bureau Web site. Available at: http://www.census.gov/hhes/www/cpstables/ 032011/health/h01-001.htm. Accessed March 2, 2010.
33. Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:301-305.
34. US Department of Health and Human Services, Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ ndfs-2007.pdf. Accessed January 31, 2010.
35. National Heart, Lung and Blood Institute. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. National Heart, Lung, and Blood Institute Web site. Available at: http://www.nhlbi.nih.gov/resources/docs/06a- ip-chtbk.pdf. Published May 2006. Accessed April 6, 2008.
36. US Bureau of Labor Statistics. National Compensation Survey: Occupational Wages in the United States, July 2003. (Bulletin 2568). US Bureau of Labor Statistics Web site. Available at: http://stats.bls.gov/ncs/ocs/sp/ncbl0658.pdf. Published September 2004. Accessed February 10, 2010.
37. Blumenthal D. Employer-sponsored insurance - riding the health care tiger. N Engl J Med. 2006;355:195-202.
38. Blumenthal D. Employer-sponsored health insurance in the United States - origins and implications. N Engl J Med. 2006;355:82-88.
39. Collins SR, Davis K, Ho A. A shared responsibility: US employers and the provision of health insurance to employees. Inquiry. 2005;42:6-15.
40. Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the Medical Expenditure Panel Survey. Med Care. 2009;47:618-625.